149 related articles for article (PubMed ID: 2997981)
21. Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.
Dillner J; Kallin B; Klein G; Jörnvall H; Alexander H; Lerner R
EMBO J; 1985 Jul; 4(7):1813-8. PubMed ID: 2992945
[TBL] [Abstract][Full Text] [Related]
22. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
[TBL] [Abstract][Full Text] [Related]
23. Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen.
Fox R; Sportsman R; Rhodes G; Luka J; Pearson G; Vaughan J
J Clin Invest; 1986 May; 77(5):1539-47. PubMed ID: 2422209
[TBL] [Abstract][Full Text] [Related]
24. Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.
Grogan EA; Summers WP; Dowling S; Shedd D; Gradoville L; Miller G
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7650-3. PubMed ID: 6324183
[TBL] [Abstract][Full Text] [Related]
25. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells.
Rabson M; Heston L; Miller G
Proc Natl Acad Sci U S A; 1983 May; 80(9):2762-6. PubMed ID: 6302703
[TBL] [Abstract][Full Text] [Related]
26. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
[TBL] [Abstract][Full Text] [Related]
27. Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans.
Wong KM; Levine AJ
J Virol; 1986 Oct; 60(1):149-56. PubMed ID: 3018282
[TBL] [Abstract][Full Text] [Related]
28. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
29. Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1.
Rowe D; Heston L; Metlay J; Miller G
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7429-33. PubMed ID: 2997790
[TBL] [Abstract][Full Text] [Related]
30. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
31. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
32. Clonality and methylation status of the Epstein-Barr virus (EBV) genomes in in vivo-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines.
Lewin N; Minarovits J; Weber G; Ehlin-Henriksson B; Wen T; Mellstedt H; Klein G; Klein E
Int J Cancer; 1991 Apr; 48(1):62-6. PubMed ID: 1850384
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a cDNA clone corresponding to a transcript from the Epstein-Barr virus BamHI M fragment: evidence for overlapping mRNAs.
Pfitzner AJ; Strominger JL; Speck SH
J Virol; 1987 Sep; 61(9):2943-6. PubMed ID: 2441081
[TBL] [Abstract][Full Text] [Related]
34. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
Dambaugh T; Hennessy K; Chamnankit L; Kieff E
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7632-6. PubMed ID: 6209719
[TBL] [Abstract][Full Text] [Related]
35. Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.
Slovin SF; Frisman DM; Tsoukas CD; Royston I; Baird SM; Wormsley SB; Carson DA; Vaughan JH
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2649-53. PubMed ID: 6283539
[TBL] [Abstract][Full Text] [Related]
36. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.
Gergely L; Luka J; Klein G
J Gen Virol; 1984 Nov; 65 ( Pt 11)():2043-8. PubMed ID: 6094716
[TBL] [Abstract][Full Text] [Related]
37. Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments.
Grogan E; Miller G; Henle W; Rabson M; Shedd D; Niederman JC
J Virol; 1981 Dec; 40(3):861-9. PubMed ID: 6275121
[TBL] [Abstract][Full Text] [Related]
38. A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.
Sixbey JW; Shirley P; Sloas M; Raab-Traub N; Israele V
J Infect Dis; 1991 May; 163(5):1008-15. PubMed ID: 1850440
[TBL] [Abstract][Full Text] [Related]
39. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
Lee W; Hwang YH; Lee SK; Subramanian C; Robertson ES
J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201
[TBL] [Abstract][Full Text] [Related]
40. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]